Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

The UK’s medicines regulator has released a suite of new guidelines to steer companies through its upcoming decentralized ...

Switzerland-based Philochem and Bristol Myers Squibb (NYSE: BMY) radiopharma subsidiary RayzeBio have announced a definitive agreement under which Philochem will license the exclusive worldwide rights ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...

Insmed earlier announced positive top-line results from its randomized, double-blind, placebo-controlled Phase IIb study of ...

Italian family-owned drugmaker Chiesi Group and Sweden’s Key2Brain today announced a worldwide license agreement to advance ...

The UK government has doubled the rate that pharma companies must repay on the sales of newer products to the National Health ...

Angelini Ventures has joined a syndicate of European life sciences investors to back Elkedonia, a French biotech developing a ...

South Korean biotech AriBio Co, specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of ...

Germany-based Arvato and Dutch immunology specialist argenx (Euronext: ARGX) have successfully achieved two important ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...